Sivadorai P, Cherninkova S, Bouwer S, Kamenarova K, Angelicheva D, Seeman P, Hollingsworth K, Mihaylova V, Oscar A, Dimitrova G, Kaneva R, Tournev I, Kalaydjieva L
Laboratory of Molecular Genetics, Western Australian Institute for Medical Research, Centre for Medical Research, The University of Western Australia, Perth, Australia.
Clin Genet. 2008 Jul;74(1):82-7. doi: 10.1111/j.1399-0004.2008.01024.x. Epub 2008 Jun 5.
Primary congenital glaucoma (PCG) is a genetically heterogeneous disorder of autosomal recessive inheritance, with mutations in the cytochrome P450 1B1 (CYP1B1) gene detected in an average of approximately 50% of cases worldwide. The Roma/Gypsies are considered to be a rare example of a single founder CYP1B1 mutation, E387K (identified in the Slovak Roma), accounting for 100% of disease alleles. Contrary to this concept, unusual genetic heterogeneity was revealed in this study of 21 Gypsy PCG patients from Bulgaria and 715 controls from the general Gypsy population. In our small sample of affected subjects, we identified five different CYP1B1 mutations - four known (E229K, R368H, E387K and R390C) and one novel and potentially pathogenic (F445I), which together accounted for approximately 30% of disease alleles. E387K was rare in both the patient and the control group, indicating that its high frequency in the Slovak Roma is the product of local founder effect not representative of the overall molecular pattern of PCG in the Gypsy population. Data on other Mendelian disorders and on the population genetics of the Gypsies suggest that a true founder mutation is likely to exist and has remained undetected. Our analysis of another candidate gene, MYOC, and the GLC3B and GLC3C loci did not provide support for their involvement. The molecular basis of PCG in the Gypsies is thus unresolved, and diagnostic analyses should be extended beyond the E387K mutation.
原发性先天性青光眼(PCG)是一种常染色体隐性遗传的基因异质性疾病,在全球范围内,平均约50%的病例中检测到细胞色素P450 1B1(CYP1B1)基因突变。罗姆人/吉普赛人被认为是单一始祖CYP1B1突变(E387K,在斯洛伐克罗姆人中发现)的罕见例子,该突变占疾病等位基因的100%。与这一概念相反,在这项对21名来自保加利亚的吉普赛PCG患者和715名来自吉普赛普通人群的对照者的研究中,发现了不同寻常的基因异质性。在我们少量的受影响受试者样本中,我们鉴定出了五种不同的CYP1B1突变——四种已知突变(E229K、R368H、E387K和R390C)以及一种新的潜在致病突变(F445I),这些突变共同约占疾病等位基因的30%。E387K在患者组和对照组中都很罕见,这表明它在斯洛伐克罗姆人中的高频率是局部始祖效应的产物,并不代表吉普赛人群中PCG的整体分子模式。关于其他孟德尔疾病和吉普赛人群遗传学的数据表明,可能存在一个真正的始祖突变但尚未被发现。我们对另一个候选基因MYOC以及GLC3B和GLC3C基因座的分析并未支持它们与该病有关。因此,吉普赛人PCG的分子基础尚未明确,诊断分析应扩展到E387K突变以外。